| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 08/27/2013 | US8519186 Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptors |
| 08/27/2013 | US8518979 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof |
| 08/27/2013 | CA2462675C Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 08/22/2013 | US20130217706 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 08/21/2013 | EP2628724A1 Aryloxyurea compound and pest control agent |
| 08/21/2013 | CN102321231B Method for preparing hexamethylene diisocyanate biuret curing agent |
| 08/21/2013 | CN101602695B Benzoyl urea compound with oxime ether structure as well as preparation method and application thereof |
| 08/14/2013 | CN103242201A Preparation method of urea formaldehyde intermediate dimethylol urea |
| 08/14/2013 | CN101942357B Method for isolating jatropha curcas oil polyunsaturated fatty acids |
| 08/13/2013 | US8507560 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity |
| 08/13/2013 | CA2526454C Gel-assisted production of small particles |
| 08/07/2013 | CN103232371A Method for preparing N-methyl-N', N'-diphenylcarbamide |
| 08/07/2013 | CN101331114B 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors |
| 07/24/2013 | CN103214400A Preparation method of hexaflumuron |
| 07/24/2013 | CN103214376A Substituted 4-aminocyclohexane derivatives |
| 07/24/2013 | CN101405264B Piperidinyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 07/23/2013 | US8492365 7-substituted tetracycline compounds |
| 07/23/2013 | CA2575033C Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/18/2013 | US20130184279 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 07/17/2013 | EP2615082A2 Production of carbamates by means of base-catalyzed Lossen rearrangement |
| 07/17/2013 | CN102432790B Method for preparing polyurethane curing agent |
| 07/16/2013 | US8487129 Heterodimers of glutamic acid |
| 07/11/2013 | US20130178494 Phenyl n-mustard linked to dna-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents |
| 07/11/2013 | DE102012100127A1 Herstellung von Carbamaten über eine basenkatalysierte Lossen- Umlagerung Preparation of carbamates via a base-catalyzed rearrangement Lossen |
| 07/10/2013 | EP2611771A1 New compounds, pharmaceutical compositions and uses thereof |
| 07/10/2013 | CN103193711A Three-ingredient eutectic ionic liquid and preparation method thereof |
| 07/10/2013 | CN103193710A Three-ingredient eutectic ionic liquid and preparation method thereof |
| 07/10/2013 | CN103193680A Preparation method of tetrabutyl urea |
| 07/09/2013 | CA2722087C 4-dimethylaminobutyric acid derivatives |
| 07/09/2013 | CA2541881C Biuret compounds, their preparation and use, and intermediates in their preparation |
| 07/03/2013 | CN103183630A Substituted 4-aminocyclohexane derivatives |
| 07/03/2013 | CN101883754B High adhesive acrylate monomer and method for preparing the same |
| 06/27/2013 | WO2013096223A1 Trpv1 antagonists |
| 06/27/2013 | WO2013091285A1 Urea compound, preparation method and use thereof |
| 06/27/2013 | US20130165479 Antagonists of the trpv1 receptor and uses thereof |
| 06/26/2013 | CN103172543A Urea compound, preparation method and application thereof |
| 06/26/2013 | CN103172542A Method for separating and purifying L-citrulline |
| 06/26/2013 | CN103172540A Phenylglycine histone deacetylase inhibitor as well as preparation method and applications thereof |
| 06/26/2013 | CN103172512A Cajanin compound with similar structures, as well as preparation method and application thereof |
| 06/20/2013 | US20130158067 TRPV1 Antagonists |
| 06/19/2013 | CN103159686A HIV-1 protease urea inhibitor |
| 06/13/2013 | WO2013086397A1 Urea compounds as gka activators |
| 06/12/2013 | CN103145588A Synthetic method of ethoxy urea |
| 06/12/2013 | CN103145587A Method for synthesizing powdered nitric acid by using allantoin synthetic waste liquid |
| 06/12/2013 | CN101817764B Preparation method of chain-like urea derivatives, cyclic urea derivatives and oxazolidinone |
| 06/11/2013 | CA2518137C Low viscosity allophanates containing actinically curable groups |
| 06/06/2013 | WO2013082302A1 Agomelatine-urea complex and crystalline forms thereof |
| 06/05/2013 | CN103130686A N,N'-asymmetric diayl substitution urea compound and preparation method and purpose thereof |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/04/2013 | US8455687 Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies |
| 06/04/2013 | US8455652 Inhibitors for the soluble epoxide hydrolase |
| 06/04/2013 | CA2551022C Polyethyleneglycol-modified lipid compounds and uses thereof |
| 06/04/2013 | CA2523840C Blocked biuretized isocyanates |
| 05/29/2013 | CN102070492B Method for synthesizing (S)-2-hydroxy-2'-(3-phenylureaphenyl)-1,1'-binaphthyl-3-formaldehyde |
| 05/23/2013 | US20130129785 Methods and compositions for delivery of active agents |
| 05/22/2013 | CN103113265A Method for synthesizing symmetric urea compounds from nitrocompounds |
| 05/16/2013 | WO2013070600A1 Aryl urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/16/2013 | WO2013070118A1 (3k,4k,58)-4-acylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-ene carboxylic acids, esters thereof and method of use |
| 05/16/2013 | US20130123496 Aryl urea derivatives as n-formyl peptide receptors like-1 (fprl-1) receptor modulators |
| 05/16/2013 | US20130123300 Urea compounds and use thereof for inhibiting apoptosis |
| 05/16/2013 | CA2855195A1 Aryl urea derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/15/2013 | EP2590937A1 Phenoxypropanol derivatives and their use in treating cardiac and cardiovascular diseases |
| 05/10/2013 | WO2013064029A1 Benzoylurea derivative with anticancer activity and preparation method and use thereof |
| 05/09/2013 | US20130116318 Enzyme Inhibitors |
| 05/08/2013 | CN103086925A Benzoyl urea derivatives having anticancer activity and their preparation method and use |
| 05/02/2013 | WO2013062947A1 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/02/2013 | WO2013062028A1 Hiv replication inhibitor |
| 05/02/2013 | WO2013060889A1 Compounds for the treatment of influenza |
| 05/02/2013 | US20130109866 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/02/2013 | CA2853715A1 Compounds for the treatment of influenza |
| 05/02/2013 | CA2853648A1 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 04/30/2013 | CA2584342C Improved inhibitors for the soluble epoxide hydrolase |
| 04/25/2013 | WO2013056559A1 Modified diphenylmethane diisocyanate biuret curing agent and preparation method thereof |
| 04/24/2013 | EP2583962A2 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient |
| 04/24/2013 | EP2582354A2 Amino acid derivatives; compositions containing them; use as agents for treating human perspiration |
| 04/24/2013 | CN103059261A Modified diphenylmethane diisocyanate biuret curing agent and preparation method thereof |
| 04/24/2013 | CN102001969B Method for shifting ammonia in diphenyl urea reaction system by nitrogen |
| 04/23/2013 | US8426426 Gyrase inhibitors and uses thereof |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096138 Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating aids, containing same as active ingredient |
| 04/18/2013 | US20130092047 Water/oil repellent agent and water/oil repellent composition |
| 04/17/2013 | CN103044287A Synthetic method for diaryl urea compound |
| 04/17/2013 | CN102180813B Method for preparing diflubenzuron serving as pesticide |
| 04/17/2013 | CN102134207B Urea compound and preparation method and application thereof |
| 04/17/2013 | CN101786969B Method of joint production of urea hydrogen peroxide and sodium percarbonate |
| 04/17/2013 | CN101538483B Poly-generation technique for using coal gas and coke oven gas as raw materials |
| 04/09/2013 | CA2510785C Substituted amides |
| 04/04/2013 | DE112011101335T5 Modifiziertes 1,6-Hexamethylendiisocyanatbiuret-Härtungsmittel sowie ein Herstellungsverfahren für dieses 1,6-hexamethylene diisocyanate biuret modified curing agent and a manufacturing method for this |
| 04/03/2013 | CN103012212A Water-soluble antibiotic synthesized by bacillus thuringiensis strain with number HD-1 |
| 04/03/2013 | CN103012211A Method for preparing bi-hydroxyalkyl urea compound by using ionic liquid catalysis |
| 03/28/2013 | US20130078283 Novel amphiphiles |
| 03/27/2013 | CN103003236A Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating AIDS, containing same as active ingredient |
| 03/27/2013 | CN102993054A Benzamide derivative and preparation method and application thereof |
| 03/27/2013 | CN102993053A Electronegative plasma assisted carbon dioxide emission reduction processing method and device thereof |
| 03/27/2013 | CN101146786B Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 03/26/2013 | US8404455 Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
| 03/21/2013 | US20130072491 Prophylactic or therapeutic agent for diabetes or obesity |
| 03/20/2013 | EP2570408A1 Hexaketide compound and medicinal use thereof |
| 03/20/2013 | EP2570403A1 Urea compounds and use thereof for inhibiting apoptosis |
| 03/20/2013 | CN102985402A Tranylcypromine derivatives as inhibitors of histone demethylase LSD1 and/or LSD2 |